Showing results (2101-2110 of 2,168) with videos related to
Sort By:
Pageof 217
Nature|June 26, 2024
Megastudy shows that reminders boost vaccination but adding free rides does notKatherine L Milkman, Sean F Ellis, Dena M Gromet, et al.Elife|March 5, 2021
Sequential perturbations to mouse corticogenesis following in utero maternal immune activationCesar P Canales, Myka L Estes, Karol Cichewicz, et al.Blood|August 9, 2013
STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patientsAndres Jerez, Michael J Clemente, Hideki Makishima, et al.Journal of Geriatric Oncology|April 5, 2021
The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancerJulie A Kish, Qiang Zhang, Corey J Langer, et al.Nature|August 26, 2021
Direct observation of ultrafast hydrogen bond strengthening in liquid waterJie Yang, Riccardo Dettori, J Pedro F Nunes, et al.Pituitary|November 19, 2021
Mice with gene alterations in the GH and IGF familyYanrong Qian, Darlene E Berryman, Reetobrata Basu, et al.Cell Host & Microbe|July 4, 2020
Arrhythmic Gut Microbiome Signatures Predict Risk of Type 2 DiabetesSandra Reitmeier, Silke Kiessling, Thomas Clavel, et al.Cancer Research|December 30, 2010
Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinaseLi Zhou, Christine McMahon, Tushar Bhagat, et al.Journal of Oral Rehabilitation|April 5, 2021
Diagnostic criteria for temporomandibular disorders (DC/TMD) for children and adolescents: An international Delphi study-Part 1-Development of Axis IRoberto Rongo, EwaCarin Ekberg, Ing-Marie Nilsson, et al.Blood|July 31, 2020
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotypeDavid A Sallman, Amy F McLemore, Amy L Aldrich, et al.Pageof 217